3//SEC Filing
Harbin Pharmaceutical Group Co., Ltd. 3
Accession 0000899243-18-029323
CIK 0001502034other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 5:07 PM ET
Size
5.4 KB
Accession
0000899243-18-029323
Insider Transaction Report
Form 3
Holdings
Series A Convertible Preferred Stock
Exercise: $5.35→ Class A Common Stock (18,691,588 underlying)
Footnotes (2)
- [F1]Each share of Series A Convertible Preferred Stock accrues dividends quarterly at an annual rate of 6.50% of the Stated Value. Dividends are payable, at the Issuer's option, in cash or in kind by issuing additional shares of Convertible Preferred Stock or by increasing the Stated Value by the amount per share of the dividend, or a combination thereof. Each share of Series A Convertible Preferred Stock is convertible, at the option of the holder, into a number of shares of the Issuer's Class A Common Stock calculated by dividing the Stated Value, plus any accumulated and unpaid dividends on such share of Series A Convertible Preferred Stock, by the conversion price. "Stated Value" means a per share value of $1,000, subject to increase in connection with the payment of dividends in kind as described above.
- [F2]Harbin Pharmaceutical Group Co., Ltd holds 100,000 shares of Series A Convertible Preferred Stock.
Documents
Issuer
GNC HOLDINGS, INC.
CIK 0001502034
Entity typeother
IncorporatedChina
Related Parties
1- filerCIK 0001759402
Filing Metadata
- Form type
- 3
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 5:07 PM ET
- Size
- 5.4 KB